USANA Health Sciences : Investor Overview Q1 2024

INVESTOR

OVERVIEW

NYSE: USNA

May 2024

SAFE HARBOR

Forward-Looking Statements.

This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including: global economic conditions generally, including continued inflationary pressure around the world and negative impact on our operating costs, consumer demand and consumer behavior in general; reliance upon our network of independent Associates; risk associated with governmental regulation of our products, manufacturing and direct selling business model in the United States, China and other key markets; potential negative effects of deteriorating foreign and/or trade relations between or among the United States, China and other key markets; potential negative effects from geopolitical relations and conflicts around the world, including the Russia-Ukraine conflict and the conflict in Israel; compliance with data privacy and security laws and regulations in our markets around the world; potential negative effects of material breaches of our information technology systems to the extent we experience a material breach; material failures of our information technology systems; adverse publicity risks globally; risks associated with commencing operations in India and future international expansion and operations; uncertainty relating to the fluctuation in U.S. and other international currencies; and the potential for a resurgence of COVID-19, or another pandemic, in any of our markets in the future and any related impact on consumer health, domestic and world economies, including any negative impact on discretionary spending, consumer demand, and consumer behavior in general. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission. The forward-looking statements in this presentation set forth our beliefs as of the date hereof. We do not undertake any obligation to update any forward-looking statement after the date hereof or to conform such statements to actual results or changes in the

Company's expectations, except as required by law.

Non-GAAP Financial Measures.

The Company prepares its financial statements using U.S. generally accepted accounting principles ("GAAP"). Constant currency net sales, earnings, EPS and other currency-related financial information (collectively, "Financial Results") are non-GAAP financial measures that remove the

impact of fluctuations in foreign-currency exchange rates ("FX") and help facilitate period-to-period comparisons of the Company's Financial Results that we believe provide investors an additional perspective on trends and underlying business results. Constant currency Financial Results are calculated by translating the current period's Financial Results at the same average exchange rates in effect during the applicable prior year period and then comparing this amount to the prior-year period's Financial Results. Free cash flow ("FCF") is a non-GAAP financial measure that we believe provides investors an additional perspective on cash flow from operating activities in excess of amounts required for reinvestment. We believe it provides a measure of our ability to fund various discretionary business initiatives, including acquisitions and share repurchase. Free cash flow is calculated by subtracting net capital expenditures from net cash provided by operating activities.

1

USANA At-A-Glance

USANA develops and manufactures high-quality,science-based nutritional and personal care products with a primary focus on promoting long-term health and wellness.

Key Investment Highlights

1. Leading provider of high-quality nutritional supplements with global scale and 30+ years of history

1. Differentiated nutritional products backed by scientific research and in-house production capabilities

1. Low capital intensity business model and solid cash flow generation

1. Strong balance sheet with essentially zero debt

1. Presence in attractive markets

1. Positioned to benefit from growing consumer focus on personal health and wellness

3

5-Pronged Approach to Profitable Growth

Active Customer

Growth

5

Active Customers

Key leading indicator for sales momentum

Direct Selling Model:

A Key Driver of Operating Leverage

USANA distributes its products internationally through a direct sales network of individual business owners (Associates).

USANA Direct

Selling Model

7

High-Quality,Science-Based Products…

Product formulations based on the latest scientific research

• On-siteR&D labs and facilities
• 60+ scientists on staff

Highest quality raw ingredients for optimal bioavailability

9